Stay updated on Imatinib in Recurrent Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.

Latest updates to the Imatinib in Recurrent Psoriasis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays Revision: v3.4.2 instead of Revision: v3.4.1, indicating a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page footer.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a new Locations section with Maryland as a location, expanding where the study is conducted. The page footer now shows Revision: v3.3.3, and the Maryland Locations entry was removed.SummaryDifference0.2%

- Check91 days agoChange DetectedEditorial edits to the Publications section clarify that publications are automatically populated from PubMed and may not all pertain to the study, and update the revision label to v3.3.2. The prior text stated that publications came from PubMed and listed revision as v3.2.0.SummaryDifference0.1%

- Check99 days agoChange DetectedRemoved the government funding status banner warning about potential delays in updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Imatinib in Recurrent Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.